Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LPA,Apolipoprotein(a),Inverse variance weighted,38,1.16 [1.12-1.2],6.60795042030523e-18,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,5,1.28 [1.2-1.36],1.4653171472124e-14,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,APOE,Apolipoprotein E,Inverse variance weighted,23,0.9 [0.86-0.95],1.05913724560979e-05,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FURIN,Furin,Wald ratio,1,1.26 [1.12-1.43],0.000128739659236791,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NRP1,Neuropilin-1,Inverse variance weighted,12,0.9 [0.85-0.96],0.000584593807569604,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ITGAV,Integrin alpha-V,Inverse variance weighted,5,1.27 [1.09-1.47],0.00178538289544906,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,0.76 [0.63-0.9],0.00195883946813647,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,0.84 [0.75-0.94],0.00210795223751346,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,1.43 [1.13-1.8],0.00266979058442727,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CCN4,CCN family member 4,Inverse variance weighted,27,1.06 [1.02-1.11],0.00444247868005879,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,1.08 [1.02-1.14],0.00510695122699665,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.85 [0.76-0.95],0.00514875186026331,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FGA,Fibrinogen alpha chain,Inverse variance weighted,7,0.84 [0.74-0.95],0.00522586880810757,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,0.94 [0.89-0.98],0.00531930396594817,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IDUA,Alpha-L-iduronidase,Inverse variance weighted,35,0.96 [0.93-0.99],0.00667824455741673,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.18 [1.05-1.33],0.00720010704404018,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,DSC2,Desmocollin-2,Inverse variance weighted,9,0.89 [0.81-0.97],0.00831247163774815,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MEP1B,Meprin A subunit beta,Inverse variance weighted,46,1.03 [1.01-1.05],0.00895195372741917,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,33,1.07 [1.02-1.13],0.00982265943614645,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.14 [1.03-1.26],0.0118702292169621,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PGA4,Pepsin A-4,Inverse variance weighted,2,1.41 [1.07-1.87],0.0146276445701926,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,UMOD,Uromodulin,Inverse variance weighted,29,1.03 [1.01-1.06],0.0156559218363498,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,INHBC,Inhibin beta C chain,Inverse variance weighted,29,1.04 [1.01-1.07],0.0156575141468288,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LAYN,Layilin,Inverse variance weighted,20,0.93 [0.87-0.99],0.0164288911184988,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,2.1 [1.13-3.89],0.0185894106435811,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,F7,Coagulation factor VII,Inverse variance weighted,21,1.06 [1.01-1.11],0.0198099726880291,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,30,0.96 [0.93-0.99],0.021504002135316,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1.07 [1.01-1.13],0.0220349173026081,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.07 [1.01-1.14],0.0223984216133458,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,1.94 [1.1-3.44],0.0225610489992105,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,KLK4,Kallikrein-4,Inverse variance weighted,17,1.05 [1.01-1.1],0.0239449446141223,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,1.06 [1.01-1.12],0.0240809127380094,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFSF10,Tumor necrosis factor ligand superfamily member 10,Inverse variance weighted,4,1.14 [1.01-1.28],0.0268150310220695,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PTGR1,Prostaglandin reductase 1,Inverse variance weighted,12,1.05 [1.01-1.1],0.02798407822356,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.12 [1.01-1.24],0.0302049992345449,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,0.71 [0.51-0.97],0.0326138249961149,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NFASC,Neurofascin,Inverse variance weighted,15,0.94 [0.88-0.99],0.0328853648937975,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,1.07 [1.01-1.15],0.0338574833764287,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IL19,Interleukin-19,Inverse variance weighted,11,1.07 [1.01-1.14],0.0339953918765077,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,0.96 [0.92-1],0.0345177328537515,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FAM3C,Protein FAM3C,Inverse variance weighted,2,1.46 [1.02-2.1],0.037269118711312,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.81 [0.67-0.99],0.039462903438715,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,INHBB,Inhibin beta B chain,Inverse variance weighted,10,0.95 [0.9-1],0.0462378163961659,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,1.07 [1-1.15],0.0470609204123314,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1.04 [1-1.08],0.0474195102999444,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,Inverse variance weighted,16,0.94 [0.89-1],0.0480527313267459,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1.04 [1-1.08],0.0482715975034743,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,1.05 [1-1.1],0.0524946679140833,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,REN,Renin,Inverse variance weighted,4,1.11 [1-1.24],0.0538183800404012,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.07 [1-1.15],0.0557212802109849,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SERPINA5,Plasma serine protease inhibitor,Inverse variance weighted,12,1.07 [1-1.14],0.0557253453296512,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.4 [0.99-1.98],0.0562927147780245,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,0.96 [0.93-1],0.0569848907852773,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,BSG,Basigin,Wald ratio,1,0.86 [0.74-1],0.0575972556756369,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,DPP4,Dipeptidyl peptidase 4,Inverse variance weighted,9,0.93 [0.86-1],0.0582421299426876,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,1.05 [1-1.1],0.0595199001078742,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,1.1 [1-1.21],0.059664217722344,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,0.91 [0.82-1],0.0617161257274368,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MVK,Mevalonate kinase,Inverse variance weighted,2,0.81 [0.64-1.01],0.0617389133210998,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,0.97 [0.94-1],0.0628712099264481,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,14,0.94 [0.88-1],0.0664512753121328,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,34,1.03 [1-1.05],0.0666367714157841,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,0.94 [0.88-1.01],0.0708328741461029,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD46,Membrane cofactor protein,Wald ratio,1,1.24 [0.98-1.57],0.0711589009380401,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,1.14 [0.99-1.32],0.0736022661587468,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,9,0.93 [0.86-1.01],0.0743419921598478,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,0.94 [0.88-1.01],0.0795632987075018,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,BPIFB2,BPI fold-containing family B member 2,Inverse variance weighted,17,0.94 [0.87-1.01],0.0816571915865202,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,RBP2,Retinol-binding protein 2,Wald ratio,1,1.36 [0.96-1.92],0.0816935175010349,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,0.96 [0.93-1],0.0817494630001897,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.88 [0.76-1.02],0.0832533576846171,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FBLN2,Fibulin-2,Inverse variance weighted,11,1.05 [0.99-1.11],0.0843958119064879,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CSTB,Cystatin-B,Inverse variance weighted,28,1.04 [1-1.08],0.0845510577032052,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,0.95 [0.89-1.01],0.0864762407401039,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NRP2,Neuropilin-2,Inverse variance weighted,11,1.08 [0.99-1.17],0.0895629463555746,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,1.09 [0.99-1.21],0.0937380921659724,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,RTN4R,Reticulon-4 receptor,Inverse variance weighted,15,1.05 [0.99-1.11],0.0937517423835909,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,1.12 [0.98-1.28],0.0960193933146746,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SCG3,Secretogranin-3,Inverse variance weighted,32,1.03 [0.99-1.08],0.0963156229216074,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1.13 [0.98-1.3],0.09847371772217,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,GHR,Growth hormone receptor,Inverse variance weighted,38,0.98 [0.95-1],0.100693109908682,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,0.84 [0.68-1.04],0.102374882885252,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,KLK14,Kallikrein-14,Inverse variance weighted,15,1.04 [0.99-1.09],0.103140627753369,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,0.73 [0.51-1.07],0.105143271451532,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PI3,Elafin,Inverse variance weighted,10,1.05 [0.99-1.12],0.106188193523705,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LGALS4,Galectin-4,Inverse variance weighted,4,1.11 [0.98-1.27],0.111255088272048,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PLAT,Tissue-type plasminogen activator,Wald ratio,1,0.72 [0.48-1.08],0.112854463199445,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ELN,Elastin,Inverse variance weighted,2,1.25 [0.95-1.64],0.118261715615961,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SEPTIN8,Septin-8,Inverse variance weighted,2,1.12 [0.97-1.3],0.123927008445548,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MUC13,Mucin-13,Inverse variance weighted,9,0.93 [0.85-1.02],0.124842800587612,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,GAL,Galanin peptides,Inverse variance weighted,3,0.82 [0.63-1.06],0.126828258385664,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,0.91 [0.8-1.03],0.127882133681503,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,0.94 [0.87-1.02],0.131866681855297,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,1.02 [0.99-1.06],0.132496216761319,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,STC1,Stanniocalcin-1,Inverse variance weighted,2,1.27 [0.93-1.74],0.132730252874383,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,1.04 [0.99-1.09],0.132912005135739,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.15 [0.96-1.39],0.133698433417399,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,1.06 [0.98-1.14],0.135031434204389,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,KLK11,Kallikrein-11,Inverse variance weighted,6,1.04 [0.99-1.1],0.136570336014646,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,7,1.1 [0.97-1.26],0.137644499915568,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MMP7,Matrilysin,Inverse variance weighted,13,1.05 [0.98-1.13],0.139359386369616,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,0.95 [0.88-1.02],0.142582916967924,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,KLKB1,Plasma kallikrein,Inverse variance weighted,15,1.03 [0.99-1.08],0.146154367821279,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,1.06 [0.98-1.16],0.14814038133318,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.14 [0.95-1.37],0.149111373516194,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,1.32 [0.9-1.94],0.152707537242691,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,15,0.95 [0.89-1.02],0.156377647549075,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SFTPD,Pulmonary surfactant-associated protein D,Inverse variance weighted,31,1.02 [0.99-1.05],0.158868939426052,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FABP6,Gastrotropin,Wald ratio,1,0.89 [0.76-1.05],0.16274314836667,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NPPB,Natriuretic peptides B,Inverse variance weighted,3,0.92 [0.82-1.03],0.163200174135194,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,0.96 [0.91-1.02],0.165607473074989,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,0.94 [0.85-1.03],0.166153680912858,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,14,1.09 [0.97-1.22],0.167009866710207,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,0.97 [0.93-1.01],0.1670744231759,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,0.92 [0.81-1.04],0.167148028820298,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,1.15 [0.94-1.39],0.167798716081787,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,2,0.7 [0.41-1.17],0.173060937687209,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,RSPO3,R-spondin-3,Inverse variance weighted,6,1.09 [0.96-1.23],0.178716622570009,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,10,0.96 [0.9-1.02],0.185895254166746,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,8,0.94 [0.85-1.03],0.186876476221747,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TCN2,Transcobalamin-2,Inverse variance weighted,34,1.03 [0.99-1.07],0.18706722808648,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CDH2,Cadherin-2,Inverse variance weighted,3,1.16 [0.93-1.43],0.188485472090091,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,24,1.03 [0.99-1.07],0.190735300919943,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,46,1.02 [0.99-1.04],0.191676534516928,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SNCG,Gamma-synuclein,Inverse variance weighted,36,0.98 [0.95-1.01],0.194019256203486,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,0.91 [0.8-1.05],0.194340833906504,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,AMBP,Protein AMBP,Inverse variance weighted,3,0.91 [0.79-1.05],0.195983314082644,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,1.03 [0.98-1.08],0.196939922954866,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,0.98 [0.95-1.01],0.198568713128294,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,11,0.96 [0.89-1.02],0.198911393805781,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ROBO2,Roundabout homolog 2,Inverse variance weighted,2,0.82 [0.6-1.11],0.200927811518692,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,12,0.92 [0.81-1.04],0.202192830732916,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,RNASE4,Ribonuclease 4,Inverse variance weighted,11,0.95 [0.87-1.03],0.204544939568114,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CTSL,Cathepsin L1,Wald ratio,1,0.75 [0.47-1.17],0.205523506716914,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,44,1.02 [0.99-1.06],0.205575940784326,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,0.88 [0.73-1.07],0.207024849668836,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,1.03 [0.98-1.08],0.208601445365497,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.95 [0.87-1.03],0.213179221357787,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CALCA,Calcitonin,Inverse variance weighted,5,0.9 [0.77-1.06],0.214272300332195,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.12 [0.93-1.35],0.215056700272177,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PALM,Paralemmin-1,Inverse variance weighted,6,1.09 [0.95-1.25],0.215281528191654,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,41,1.01 [0.99-1.04],0.215880589388319,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,6,0.95 [0.87-1.03],0.21640644118812,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD83,CD83 antigen,Inverse variance weighted,5,1.07 [0.96-1.19],0.216428921514379,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CCL18,C-C motif chemokine 18,Inverse variance weighted,15,0.97 [0.94-1.02],0.217832114441475,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,OGN,Mimecan,Inverse variance weighted,30,0.97 [0.93-1.02],0.218170824419626,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,0.97 [0.92-1.02],0.22118808616533,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,3,0.88 [0.72-1.08],0.222950072531509,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.94 [0.85-1.04],0.237396151687633,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,1.05 [0.97-1.15],0.23851373770238,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,VSNL1,Visinin-like protein 1,Inverse variance weighted,8,0.89 [0.74-1.08],0.238567385435094,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TGFBI,Transforming growth factor-beta-induced protein ig-h3,Inverse variance weighted,32,1.02 [0.98-1.07],0.239804909136244,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,8,0.96 [0.89-1.03],0.24029457492758,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CTSD,Cathepsin D,Inverse variance weighted,17,0.96 [0.91-1.02],0.24175041955277,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,1.05 [0.97-1.15],0.242835921332299,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,0.94 [0.85-1.04],0.242967844701773,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PENK,Proenkephalin-A,Inverse variance weighted,19,0.96 [0.91-1.03],0.248418397852876,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,29,1.02 [0.99-1.05],0.251571696205267,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,0.96 [0.89-1.03],0.256240717587007,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,0.97 [0.91-1.03],0.257291122593377,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,1.08 [0.95-1.22],0.257596659941443,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD34,Hematopoietic progenitor cell antigen CD34,Wald ratio,1,1.23 [0.86-1.76],0.257907327205622,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,27,0.98 [0.96-1.01],0.259282143768189,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SOST,Sclerostin,Wald ratio,1,1.25 [0.85-1.83],0.264385365069115,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,1.03 [0.98-1.08],0.267107516724787,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,Inverse variance weighted,21,1.04 [0.97-1.1],0.26875913471493,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.12 [0.92-1.36],0.270267427594614,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SDC1,Syndecan-1,Inverse variance weighted,2,1.19 [0.87-1.63],0.271242559324448,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,KLB,Beta-klotho,Inverse variance weighted,32,0.98 [0.95-1.01],0.272075966040534,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Inverse variance weighted,3,1.08 [0.94-1.24],0.275403941454717,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,1.03 [0.98-1.07],0.27669305848553,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,1.06 [0.95-1.19],0.27832906148665,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,24,0.97 [0.92-1.03],0.283509658910717,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,1.02 [0.99-1.05],0.284503297392933,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CCL22,C-C motif chemokine 22,Inverse variance weighted,6,0.95 [0.86-1.04],0.284686812614465,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,17,1.03 [0.97-1.09],0.285540967194188,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,1.03 [0.97-1.09],0.289452994825901,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,4,0.94 [0.85-1.05],0.293970804333274,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,1.03 [0.97-1.1],0.295387718065996,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,1.12 [0.91-1.37],0.297078633668659,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,RNASET2,Ribonuclease T2,Inverse variance weighted,14,0.98 [0.93-1.02],0.301066659368764,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,26,0.97 [0.91-1.03],0.30449424261519,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CFI,Complement factor I,Inverse variance weighted,6,0.92 [0.8-1.07],0.305862076774447,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,1.22 [0.83-1.8],0.308837459198935,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MB,Myoglobin,Wald ratio,1,1.34 [0.77-2.33],0.308860296471617,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SPP1,Osteopontin,Inverse variance weighted,8,1.1 [0.91-1.33],0.312831585963644,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,2,0.94 [0.83-1.06],0.314859631200751,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,0.79 [0.51-1.25],0.315757055276212,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1.05 [0.95-1.15],0.315996591471328,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CLEC4M,C-type lectin domain family 4 member M,Inverse variance weighted,21,0.98 [0.94-1.02],0.316805660454793,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CCL16,C-C motif chemokine 16,Inverse variance weighted,19,1.02 [0.98-1.05],0.317776658836541,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,4,0.95 [0.86-1.05],0.320104489867005,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,EFNA1,Ephrin-A1,Inverse variance weighted,11,1.05 [0.96-1.15],0.323665614539821,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,0.91 [0.76-1.1],0.324590074104882,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,1.05 [0.96-1.15],0.324667753014063,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CFH,Complement factor H,Inverse variance weighted,19,0.97 [0.91-1.03],0.325100846918054,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IL7R,Interleukin-7 receptor subunit alpha,Inverse variance weighted,47,0.99 [0.96-1.01],0.329231437626414,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ACE,Angiotensin-converting enzyme,Inverse variance weighted,26,1.02 [0.98-1.07],0.329248709443109,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Wald ratio,1,0.88 [0.68-1.14],0.336400268802993,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,6,1.06 [0.94-1.2],0.336469639029803,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,1.04 [0.96-1.14],0.336914920482714,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,0.96 [0.87-1.05],0.33697945706046,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CREG1,Protein CREG1,Inverse variance weighted,3,0.95 [0.84-1.06],0.339994833582817,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,30,1.03 [0.97-1.08],0.34216888614589,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,1.01 [0.98-1.05],0.343086029099562,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,0.98 [0.95-1.02],0.346362420282485,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MFGE8,Lactadherin,Inverse variance weighted,11,1.05 [0.95-1.15],0.346486621546862,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,0.98 [0.94-1.02],0.346608571360585,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,1.02 [0.98-1.06],0.34764542192299,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,1.03 [0.97-1.1],0.348691192591107,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CALB1,Calbindin,Inverse variance weighted,2,1.13 [0.87-1.48],0.353482936649671,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,0.77 [0.45-1.33],0.355535487370874,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,3,0.96 [0.88-1.05],0.366162097269923,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SERPIND1,Heparin cofactor 2,Wald ratio,1,1.12 [0.88-1.43],0.368462143259227,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,1.04 [0.95-1.15],0.369847343395649,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD302,CD302 antigen,Inverse variance weighted,9,0.96 [0.89-1.05],0.373270246569525,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,1.04 [0.95-1.14],0.376204104284777,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,0.96 [0.87-1.05],0.376346119776247,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,0.94 [0.81-1.08],0.37713334103503,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PGF,Placenta growth factor,Inverse variance weighted,2,0.78 [0.46-1.35],0.377650744485231,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,1.03 [0.97-1.09],0.377838778219288,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,9,1.03 [0.97-1.1],0.377859669336606,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,0.96 [0.88-1.05],0.37902165266294,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,EPO,Erythropoietin,Inverse variance weighted,5,0.9 [0.7-1.14],0.379142893091511,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CHGB,Secretogranin-1,Inverse variance weighted,27,0.99 [0.95-1.02],0.396249054750393,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,HYAL1,Hyaluronidase-1,Inverse variance weighted,5,0.95 [0.85-1.07],0.397632175487047,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MENT,Protein MENT,Inverse variance weighted,3,1.02 [0.97-1.07],0.398882839503056,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD58,Lymphocyte function-associated antigen 3,Inverse variance weighted,4,0.95 [0.84-1.07],0.401195403809522,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,14,1.02 [0.97-1.08],0.40148781773055,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,1.02 [0.97-1.07],0.402501387178929,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,0.97 [0.91-1.04],0.407269134831752,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,1.07 [0.91-1.27],0.408387468150788,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CTSS,Cathepsin S,Inverse variance weighted,23,1.02 [0.97-1.08],0.411134058858419,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,0.92 [0.76-1.12],0.414808690421634,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CCN1,CCN family member 1,Inverse variance weighted,2,0.93 [0.77-1.12],0.422344824955309,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ITGA11,Integrin alpha-11,Inverse variance weighted,8,1.04 [0.95-1.14],0.424038845511452,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SHISA5,Protein shisa-5,Inverse variance weighted,5,0.92 [0.74-1.13],0.425754292910141,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,HSPB6,Heat shock protein beta-6,Wald ratio,1,1.24 [0.73-2.09],0.427596478148984,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,1.02 [0.96-1.09],0.428393062162546,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CCL25,C-C motif chemokine 25,Inverse variance weighted,26,1.02 [0.98-1.06],0.429279051421369,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FAM3B,Protein FAM3B,Inverse variance weighted,18,0.98 [0.93-1.03],0.430746034457229,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.88 [0.63-1.22],0.433517606940229,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PSAP,Prosaposin,Inverse variance weighted,5,1.04 [0.95-1.14],0.434104779167446,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,20,1.01 [0.98-1.05],0.434631207891656,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LDLR,Low-density lipoprotein receptor,Wald ratio,1,1.43 [0.58-3.51],0.43515427426729,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,28,1.03 [0.96-1.1],0.435481897854496,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,0.98 [0.92-1.04],0.436396974247662,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,3,0.95 [0.83-1.09],0.438815920192764,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,3,0.91 [0.72-1.15],0.442271183639973,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LGALS9,Galectin-9,Inverse variance weighted,26,0.98 [0.94-1.03],0.442298258327989,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CGA,Glycoprotein hormones alpha chain,Wald ratio,1,0.79 [0.43-1.45],0.444184288519149,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,1.06 [0.91-1.24],0.448129886126961,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LGMN,Legumain,Inverse variance weighted,12,1.02 [0.97-1.08],0.451859448715853,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,4,1.06 [0.91-1.22],0.458490336525192,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,0.98 [0.92-1.04],0.461742067808264,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,1.03 [0.96-1.1],0.462590656961886,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,1.03 [0.96-1.1],0.463429095718021,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,KLK8,Kallikrein-8,Inverse variance weighted,12,0.97 [0.89-1.06],0.472992568116697,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ANGPTL3,Angiopoietin-related protein 3,Inverse variance weighted,10,0.97 [0.91-1.05],0.474607879120667,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,10,1.02 [0.96-1.09],0.474906719894202,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,34,0.98 [0.93-1.03],0.475501184788149,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,RRM2,Ribonucleoside-diphosphate reductase subunit M2,Wald ratio,1,1.17 [0.76-1.78],0.478230091127407,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CCL23,C-C motif chemokine 23,Inverse variance weighted,17,1.01 [0.98-1.05],0.479600198478262,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,APOA1,Apolipoprotein A-I,Inverse variance weighted,2,1.33 [0.61-2.9],0.479822866899524,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,APOC1,Apolipoprotein C-I,Inverse variance weighted,6,1.06 [0.9-1.24],0.485674447879668,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,1.06 [0.91-1.23],0.487604166162879,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NPL,N-acetylneuraminate lyase,Inverse variance weighted,11,1.03 [0.95-1.11],0.487932616161397,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,AGRP,Agouti-related protein,Inverse variance weighted,3,0.89 [0.63-1.25],0.488074216103961,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PDGFC,Platelet-derived growth factor C,Wald ratio,1,1.19 [0.72-1.97],0.488527556822788,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.18 [0.74-1.86],0.489839224553261,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,THPO,Thrombopoietin,Inverse variance weighted,3,1.09 [0.85-1.41],0.49035158486114,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CNTN5,Contactin-5,Inverse variance weighted,28,1.01 [0.98-1.05],0.490835598755866,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,1.01 [0.98-1.05],0.49294392559197,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,DKK4,Dickkopf-related protein 4,Inverse variance weighted,4,0.95 [0.81-1.11],0.493350683884363,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,1.18 [0.73-1.92],0.49355427812469,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LMNB2,Lamin-B2,Wald ratio,1,0.84 [0.5-1.4],0.49412318862326,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LY96,Lymphocyte antigen 96,Inverse variance weighted,3,0.87 [0.58-1.3],0.50244485328358,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FLT3LG,Fms-related tyrosine kinase 3 ligand,Inverse variance weighted,2,1.08 [0.86-1.38],0.502865862298762,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,HGF,Hepatocyte growth factor,Inverse variance weighted,2,1.08 [0.86-1.37],0.506752761542652,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TFF2,Trefoil factor 2,Inverse variance weighted,5,0.95 [0.81-1.11],0.51639250013821,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MDK,Midkine,Inverse variance weighted,4,1.06 [0.89-1.27],0.520737971608023,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,0.95 [0.82-1.11],0.524240604588534,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,APCS,Serum amyloid P-component,Inverse variance weighted,4,0.95 [0.81-1.12],0.524402239415881,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FOLR1,Folate receptor alpha,Inverse variance weighted,5,1.04 [0.91-1.2],0.527941206942547,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,DLL1,Delta-like protein 1,Inverse variance weighted,7,1.03 [0.93-1.14],0.528855865719734,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NUCB2,Nucleobindin-2,Inverse variance weighted,24,1.02 [0.96-1.09],0.538933781237828,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,EFNA4,Ephrin-A4,Inverse variance weighted,3,0.91 [0.68-1.23],0.542684607274114,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SCG2,Secretogranin-2,Wald ratio,1,1.14 [0.74-1.78],0.549219081480572,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,1.08 [0.84-1.39],0.549476722503255,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,9,1.02 [0.95-1.09],0.554511786004605,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TFF3,Trefoil factor 3,Inverse variance weighted,5,1.03 [0.92-1.16],0.555042267127546,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,1.02 [0.96-1.08],0.556530804747608,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,DPT,Dermatopontin,Inverse variance weighted,21,0.98 [0.93-1.04],0.556801513440015,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD27,CD27 antigen,Inverse variance weighted,9,0.98 [0.92-1.04],0.557475399983809,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,APOD,Apolipoprotein D,Inverse variance weighted,7,0.98 [0.9-1.06],0.561484284572441,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,1.09 [0.81-1.46],0.567604050314361,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,1.01 [0.97-1.05],0.570105365191995,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CLIC5,Chloride intracellular channel protein 5,Inverse variance weighted,2,0.92 [0.68-1.24],0.570348620698498,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,3,0.97 [0.85-1.09],0.571813890604234,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,0.95 [0.78-1.15],0.576380134019817,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CTSZ,Cathepsin Z,Inverse variance weighted,3,1.02 [0.95-1.09],0.588993268040945,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,1.08 [0.82-1.41],0.590827863443089,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,1.13 [0.72-1.78],0.593017393733063,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,RSPO1,R-spondin-1,Inverse variance weighted,5,1.02 [0.94-1.12],0.594459486808641,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,COLEC12,Collectin-12,Inverse variance weighted,11,1.02 [0.94-1.12],0.596208825944536,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,1.01 [0.98-1.04],0.596364393253242,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FGFBP2,Fibroblast growth factor-binding protein 2,Inverse variance weighted,21,0.99 [0.95-1.03],0.599376701525541,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TFPI,Tissue factor pathway inhibitor,Inverse variance weighted,26,0.99 [0.94-1.04],0.600325318283763,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,RTBDN,Retbindin,Inverse variance weighted,3,1.03 [0.92-1.16],0.6032249587268,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,EDN1,Endothelin-1,Inverse variance weighted,3,1.02 [0.93-1.13],0.606068356960583,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.02 [0.94-1.1],0.611324942370626,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,0.96 [0.8-1.14],0.612476834654143,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,16,0.99 [0.95-1.03],0.6125026042104,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PTN,Pleiotrophin,Inverse variance weighted,4,1.06 [0.84-1.34],0.618695149311288,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PTPRB,Receptor-type tyrosine-protein phosphatase beta,Inverse variance weighted,21,1.01 [0.96-1.07],0.620031390502926,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,0.94 [0.72-1.21],0.624280115634027,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,EGFR,Epidermal growth factor receptor,Inverse variance weighted,7,0.96 [0.81-1.13],0.62586291451822,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LGALS3,Galectin-3,Inverse variance weighted,25,0.99 [0.95-1.03],0.625933723794893,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD160,CD160 antigen,Inverse variance weighted,11,0.99 [0.93-1.04],0.631233053630354,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,0.97 [0.85-1.11],0.639889024723456,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,1.04 [0.89-1.21],0.64548347051882,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,0.98 [0.92-1.06],0.649396771343082,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,0.98 [0.9-1.07],0.651308569534563,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,28,1.01 [0.97-1.04],0.652638631440021,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,0.99 [0.93-1.05],0.654151037858209,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,OCLN,Occludin,Inverse variance weighted,2,1.04 [0.88-1.22],0.6597431101504,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,1.02 [0.93-1.12],0.661523051997303,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,1.02 [0.93-1.12],0.662038070956984,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,Inverse variance weighted,34,0.99 [0.97-1.02],0.665256462315107,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PALM2,Paralemmin-2,Inverse variance weighted,8,1.02 [0.94-1.11],0.666521770019091,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,7,0.96 [0.78-1.17],0.670169106541984,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,3,0.95 [0.75-1.2],0.670990500300922,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,1.02 [0.92-1.14],0.67123693955597,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SPON2,Spondin-2,Inverse variance weighted,4,0.98 [0.88-1.09],0.673235651203398,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,7,0.97 [0.86-1.11],0.678292558522682,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,0.9 [0.54-1.49],0.678402403118136,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,1.03 [0.88-1.21],0.682845202823122,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,1.03 [0.88-1.21],0.685166387661539,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CCL27,C-C motif chemokine 27,Inverse variance weighted,4,1.02 [0.93-1.11],0.692932892835877,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LGALS1,Galectin-1,Inverse variance weighted,6,0.99 [0.93-1.05],0.695407803291173,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,1.07 [0.77-1.48],0.697110929801237,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,0.97 [0.83-1.13],0.699546737382466,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,GUCA2A,Guanylin,Inverse variance weighted,9,1.02 [0.93-1.12],0.700233839685281,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,0.94 [0.68-1.3],0.70280634118104,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,1.02 [0.93-1.12],0.710727980657589,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,0.99 [0.91-1.06],0.713222201514093,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,0.99 [0.95-1.04],0.713435708584109,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MMP3,Stromelysin-1,Inverse variance weighted,34,0.99 [0.94-1.04],0.713805136382018,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,1.05 [0.8-1.39],0.719423311237577,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,1.09 [0.67-1.79],0.721006080859971,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1.01 [0.94-1.1],0.722710779554232,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,12,1.01 [0.97-1.04],0.724462531931473,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,0.99 [0.93-1.05],0.726915988760762,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CCN5,CCN family member 5,Inverse variance weighted,8,1.03 [0.87-1.21],0.727176673273073,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,0.99 [0.91-1.07],0.728844283952228,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,1.01 [0.94-1.09],0.730207932662317,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1.01 [0.95-1.08],0.730221048921176,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CCN3,CCN family member 3,Inverse variance weighted,19,0.99 [0.92-1.06],0.734908585890837,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,0.99 [0.92-1.06],0.736802726921393,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ANG,Angiogenin,Inverse variance weighted,19,1.01 [0.96-1.05],0.736806041184631,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,0.98 [0.89-1.09],0.737024506948829,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PLTP,Phospholipid transfer protein,Inverse variance weighted,19,1.01 [0.96-1.05],0.738159910929798,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,1.02 [0.93-1.11],0.739917874172281,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,28,1.01 [0.97-1.05],0.755503981665541,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CFD,Complement factor D,Inverse variance weighted,11,1.01 [0.94-1.09],0.756199510885813,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ANXA10,Annexin A10,Wald ratio,1,0.94 [0.62-1.42],0.761218380788952,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NECTIN4,Nectin-4,Inverse variance weighted,7,1.01 [0.95-1.07],0.761553401407089,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CHGA,Chromogranin-A,Inverse variance weighted,3,1.02 [0.91-1.13],0.766109396207046,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,0.99 [0.96-1.03],0.766800947853293,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,0.99 [0.89-1.09],0.767131450264885,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,AREG,Amphiregulin,Inverse variance weighted,3,0.98 [0.84-1.14],0.767636951215302,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,KDR,Vascular endothelial growth factor receptor 2,Inverse variance weighted,16,1.01 [0.95-1.08],0.772355466534679,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,GRN,Progranulin,Inverse variance weighted,7,0.99 [0.93-1.06],0.781521288440363,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,4,1.01 [0.91-1.13],0.784991698401836,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,Inverse variance weighted,34,1 [0.97-1.03],0.786279532165379,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,1.02 [0.88-1.18],0.787998153195334,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,1.02 [0.9-1.15],0.790036505385417,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,1.02 [0.91-1.14],0.791554275951706,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TFF1,Trefoil factor 1,Inverse variance weighted,8,0.99 [0.9-1.09],0.792068087425751,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,1.02 [0.88-1.17],0.801311612092898,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,XCL1,Lymphotactin,Inverse variance weighted,31,1 [0.97-1.04],0.804425393993356,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Wald ratio,1,0.98 [0.81-1.18],0.806381471611497,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,3,0.99 [0.94-1.05],0.807039034936725,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,APOL1,Apolipoprotein L1,Inverse variance weighted,3,1.01 [0.93-1.1],0.807445251809929,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,3,1.02 [0.89-1.16],0.810101722143187,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MET,Hepatocyte growth factor receptor,Inverse variance weighted,5,1.05 [0.72-1.52],0.812047628466391,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,VWC2,Brorin,Inverse variance weighted,22,1.01 [0.95-1.06],0.821104953891784,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,1.05 [0.67-1.64],0.821657920471472,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,1.06 [0.61-1.85],0.82622781727158,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NPPC,C-type natriuretic peptide,Wald ratio,1,1.06 [0.64-1.75],0.82815823606193,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PRSS8,Prostasin,Inverse variance weighted,5,0.98 [0.85-1.14],0.831349641132021,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CST3,Cystatin-C,Inverse variance weighted,10,1.01 [0.93-1.09],0.831734652142774,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MSLN,Mesothelin,Inverse variance weighted,25,1 [0.96-1.04],0.839309145773992,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NECTIN2,Nectin-2,Inverse variance weighted,5,0.99 [0.86-1.13],0.853308414048377,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,F13B,Coagulation factor XIII B chain,Inverse variance weighted,33,1.01 [0.95-1.06],0.855799565706357,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,0.98 [0.78-1.23],0.857345700091216,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CALB2,Calretinin,Wald ratio,1,1.03 [0.73-1.45],0.859718629518144,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PLXNB2,Plexin-B2,Inverse variance weighted,27,1 [0.97-1.02],0.859979298562886,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,1.03 [0.73-1.45],0.867720686979536,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,1.01 [0.9-1.13],0.885770209887769,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ACAN,Aggrecan core protein,Inverse variance weighted,3,0.99 [0.81-1.2],0.888219479248333,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,1.01 [0.86-1.19],0.892217278108329,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.98 [0.76-1.26],0.893534672686221,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,0.99 [0.89-1.1],0.894320393210311,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,C7,Complement component C7,Inverse variance weighted,38,1 [0.98-1.03],0.897275018520104,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CPM,Carboxypeptidase M,Inverse variance weighted,4,0.99 [0.87-1.13],0.899737681921791,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,1 [0.96-1.04],0.903672331825324,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,0.98 [0.65-1.47],0.903918632216314,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SPON1,Spondin-1,Inverse variance weighted,21,1 [0.95-1.06],0.904481559676035,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,HJV,Hemojuvelin,Wald ratio,1,1.01 [0.9-1.13],0.913328954364599,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,1 [0.96-1.04],0.914742348835374,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ADM,Pro-adrenomedullin,Inverse variance weighted,2,0.99 [0.75-1.3],0.914888027765306,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SFTPA2,Pulmonary surfactant-associated protein A2,Inverse variance weighted,19,1 [0.97-1.04],0.917830863074153,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,1.01 [0.85-1.2],0.918318132561362,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CTSB,Cathepsin B,Inverse variance weighted,26,1 [0.97-1.04],0.919044698020188,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,0.98 [0.6-1.6],0.926952938751867,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,0.99 [0.82-1.2],0.935084785890051,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,8,1 [0.92-1.09],0.940854930832275,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,1 [0.89-1.13],0.953071883763734,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FOLR2,Folate receptor beta,Inverse variance weighted,2,1 [0.85-1.19],0.955090304783124,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,1 [0.93-1.07],0.956775930682424,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1 [0.98-1.02],0.958190276220029,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1 [0.94-1.06],0.958206080605711,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NPY,Pro-neuropeptide Y,Inverse variance weighted,3,1 [0.87-1.16],0.959528537401683,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Wald ratio,1,1.01 [0.75-1.36],0.960626599670133,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,AOC3,Membrane primary amine oxidase,Inverse variance weighted,18,1 [0.96-1.04],0.962711805043861,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,DPY30,Protein dpy-30 homolog,Wald ratio,1,0.99 [0.61-1.6],0.96299558816117,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,DRAXIN,Draxin,Inverse variance weighted,13,1 [0.96-1.05],0.963170077128832,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,AGRN,Agrin,Inverse variance weighted,17,1 [0.94-1.06],0.967756509596738,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,APOA2,Apolipoprotein A-II,Wald ratio,1,0.99 [0.72-1.37],0.967954488584296,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD209,CD209 antigen,Inverse variance weighted,15,1 [0.94-1.06],0.970903796803969,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,1 [0.82-1.21],0.977836977843423,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,11,1 [0.93-1.08],0.979505718321706,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,15,1 [0.94-1.07],0.986344364612685,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CA14,Carbonic anhydrase 14,Inverse variance weighted,8,1 [0.95-1.05],0.986932969763608,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,1 [0.88-1.13],0.990863439725876,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ADIPOQ,Adiponectin,Inverse variance weighted,13,1 [0.93-1.07],0.994829488974832,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,1 [0.91-1.1],0.996399981908369,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,OSM,Oncostatin-M,Wald ratio,1,1 [0.74-1.35],0.997663830913478,cis
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,13.4 [8.6-20.88],1.78746449274138e-30,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ANGPTL3,Angiopoietin-related protein 3,Inverse variance weighted,5,0.56 [0.45-0.69],7.1996912435151e-08,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NPL,N-acetylneuraminate lyase,Inverse variance weighted,5,1.37 [1.18-1.6],3.71843066131529e-05,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,18,1.64 [1.27-2.11],0.000157499637778021,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,GRN,Progranulin,Inverse variance weighted,46,1.08 [1.03-1.13],0.00051250337119956,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,12,0.79 [0.68-0.91],0.00159258258848172,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,GOLM2,Protein GOLM2,Inverse variance weighted,14,1.12 [1.04-1.21],0.00284637744716434,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,0.51 [0.32-0.79],0.00307959732525438,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,0.79 [0.68-0.92],0.00312145273353136,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,1.47 [1.14-1.9],0.00331671799122144,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,DSC2,Desmocollin-2,Inverse variance weighted,16,0.89 [0.82-0.96],0.00431302644080336,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,7,1.2 [1.06-1.36],0.0049774459445504,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,28,1.16 [1.04-1.29],0.00647805883668449,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,8,0.81 [0.69-0.95],0.00820241364746465,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TGFBI,Transforming growth factor-beta-induced protein ig-h3,Inverse variance weighted,14,0.89 [0.8-0.97],0.0117848479336336,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.14 [1.03-1.26],0.0118702292169621,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,3,1.36 [1.06-1.73],0.0145811101570775,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MSLN,Mesothelin,Inverse variance weighted,11,1.24 [1.04-1.49],0.0160761223643541,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,APOL1,Apolipoprotein L1,Inverse variance weighted,46,1.06 [1.01-1.1],0.0163694980503349,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FGA,Fibrinogen alpha chain,Inverse variance weighted,6,1.45 [1.07-1.98],0.0173932488852804,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,0.72 [0.55-0.95],0.0185170993765428,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,0.85 [0.75-0.97],0.0185657618858856,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,39,0.92 [0.86-0.99],0.0189210547162422,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,13,0.83 [0.71-0.97],0.0191959595633317,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ADIPOQ,Adiponectin,Inverse variance weighted,25,0.89 [0.81-0.98],0.0228219225402783,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,1.19 [1.02-1.38],0.0234566959053536,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,Inverse variance weighted,20,1.09 [1.01-1.18],0.0276053253998829,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,APOD,Apolipoprotein D,Inverse variance weighted,9,0.62 [0.41-0.95],0.0281184158620298,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CNTN5,Contactin-5,Inverse variance weighted,22,1.08 [1.01-1.16],0.0320093217771167,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SPON2,Spondin-2,Inverse variance weighted,3,1.36 [1.03-1.81],0.0324459607092215,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CSTB,Cystatin-B,Inverse variance weighted,23,1.05 [1-1.09],0.0326527984635386,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.15 [1.01-1.3],0.0336259958081743,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,1.13 [1.01-1.27],0.0368240280182207,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,RTBDN,Retbindin,Inverse variance weighted,2,1.64 [1.03-2.6],0.0374703466499547,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,VSNL1,Visinin-like protein 1,Inverse variance weighted,9,0.92 [0.85-1],0.0395201150381838,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NRP1,Neuropilin-1,Inverse variance weighted,14,0.87 [0.76-0.99],0.0409120983745008,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MEP1B,Meprin A subunit beta,Inverse variance weighted,72,1.03 [1-1.05],0.0420233097710449,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,1.15 [1-1.31],0.0420238617815499,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,1.06 [1-1.12],0.0422598341161618,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,KLKB1,Plasma kallikrein,Inverse variance weighted,20,0.92 [0.84-1],0.0427962221326565,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,6,0.84 [0.71-0.99],0.0434311774988703,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,WNT9A,Protein Wnt-9a,Wald ratio,1,1.83 [1.01-3.29],0.0445063108118381,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.4 [1.01-1.94],0.045077501923052,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,OSM,Oncostatin-M,Inverse variance weighted,6,1.14 [1-1.3],0.0455556515453393,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CTSD,Cathepsin D,Inverse variance weighted,7,1.2 [1-1.44],0.0508099695203922,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,KLK8,Kallikrein-8,Inverse variance weighted,5,0.8 [0.63-1],0.0511635205456722,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,AREG,Amphiregulin,Inverse variance weighted,5,1.26 [1-1.59],0.0518525346546708,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MUC13,Mucin-13,Inverse variance weighted,3,0.67 [0.45-1.01],0.0538338076953868,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.4 [0.99-1.98],0.0562927147780245,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,1.24 [0.99-1.56],0.0611745562617084,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PTGR1,Prostaglandin reductase 1,Inverse variance weighted,18,1.06 [1-1.12],0.0624185539923224,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,1.21 [0.99-1.49],0.0628152657362143,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.36 [0.98-1.87],0.0638993858139637,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,1.1 [0.99-1.22],0.0642804917617771,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.51 [0.97-2.34],0.0683822478576506,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,1.31 [0.98-1.74],0.0686808627341206,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,15,0.85 [0.72-1.01],0.0705327266821237,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,AGRP,Agouti-related protein,Inverse variance weighted,16,1.24 [0.98-1.57],0.0719258334671785,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,23,0.92 [0.85-1.01],0.0734010935296473,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ANG,Angiogenin,Inverse variance weighted,8,1.36 [0.97-1.92],0.0774603137239787,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CCN1,CCN family member 1,Inverse variance weighted,6,1.82 [0.93-3.57],0.0799245280109001,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.85 [0.7-1.02],0.0811261285103064,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,0.84 [0.69-1.02],0.0818366028689947,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,0.88 [0.76-1.02],0.0827514862925638,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,7,0.84 [0.68-1.02],0.0838510325632673,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,0.82 [0.66-1.03],0.0850321543459949,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,0.91 [0.82-1.01],0.0854872702519257,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MB,Myoglobin,Inverse variance weighted,9,0.89 [0.78-1.02],0.0876269928671506,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,APCS,Serum amyloid P-component,Inverse variance weighted,3,1.27 [0.96-1.68],0.0899382627960882,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,VWC2,Brorin,Inverse variance weighted,12,1.17 [0.97-1.4],0.0926410156466578,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MMP3,Stromelysin-1,Inverse variance weighted,4,1.42 [0.94-2.15],0.0931915886133648,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.15 [0.98-1.36],0.0935133409802702,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,1.12 [0.98-1.28],0.0945549279293566,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IDUA,Alpha-L-iduronidase,Inverse variance weighted,18,1.15 [0.98-1.36],0.0951476850968296,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,GDF15,Growth/differentiation factor 15,Wald ratio,1,1.69 [0.91-3.13],0.0953707638727769,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.16 [0.97-1.38],0.0960196737588076,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,0.86 [0.72-1.03],0.0961613525783948,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,15,1.12 [0.98-1.28],0.100228924644875,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,1.24 [0.96-1.6],0.100671192131542,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.88 [0.75-1.03],0.104089966714342,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.24 [0.96-1.6],0.104328487615365,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,APOC1,Apolipoprotein C-I,Inverse variance weighted,12,0.82 [0.64-1.04],0.106380327307063,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,C7,Complement component C7,Inverse variance weighted,26,1.04 [0.99-1.1],0.110806323258113,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CFC1,Cryptic protein,Inverse variance weighted,11,1.13 [0.97-1.32],0.112302040967592,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.94 [0.88-1.01],0.115575880095159,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,0.96 [0.91-1.01],0.117456405930336,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IL6,Interleukin-6,Inverse variance weighted,6,0.9 [0.8-1.03],0.117726218359737,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,1.14 [0.97-1.35],0.118222553769372,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,1.07 [0.98-1.17],0.120703224465491,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,EFNA1,Ephrin-A1,Inverse variance weighted,3,1.18 [0.96-1.47],0.123283937729754,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.1 [0.97-1.25],0.127236749296376,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,0.69 [0.43-1.11],0.127336863109969,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,1.12 [0.97-1.3],0.128843286628773,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MFAP5,Microfibrillar-associated protein 5,Inverse variance weighted,2,1.58 [0.87-2.87],0.130208412050572,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PI3,Elafin,Inverse variance weighted,18,1.04 [0.99-1.11],0.135529774649639,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,12,0.92 [0.83-1.03],0.13912727715139,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,KLK14,Kallikrein-14,Inverse variance weighted,15,1.09 [0.97-1.22],0.139572726084817,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NPY,Pro-neuropeptide Y,Inverse variance weighted,15,1.2 [0.94-1.53],0.139989597301576,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,1.06 [0.98-1.15],0.140106995318569,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,OGN,Mimecan,Inverse variance weighted,37,0.97 [0.93-1.01],0.143224330790475,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CFP,Properdin,Inverse variance weighted,17,0.95 [0.88-1.02],0.146173510164197,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CFD,Complement factor D,Wald ratio,1,0.72 [0.46-1.12],0.146225666608964,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,1.22 [0.93-1.61],0.150164763894758,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,APOA1,Apolipoprotein A-I,Inverse variance weighted,13,0.84 [0.67-1.07],0.152629468110383,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,7,0.9 [0.78-1.04],0.154540870621944,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,1.04 [0.99-1.09],0.155102631405423,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CPM,Carboxypeptidase M,Inverse variance weighted,19,1.11 [0.96-1.28],0.160870183369849,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CCN4,CCN family member 4,Inverse variance weighted,29,1.04 [0.98-1.1],0.166011156562131,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,4,0.9 [0.77-1.05],0.166914459159438,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,0.88 [0.73-1.06],0.169322454127077,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,47,1.05 [0.98-1.13],0.169480696692,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,21,1.04 [0.98-1.1],0.170324883918882,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,1.22 [0.92-1.62],0.176140975543179,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,1.03 [0.99-1.07],0.177703037789989,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,0.77 [0.53-1.13],0.179818147528645,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Inverse variance weighted,19,1.04 [0.98-1.11],0.181425648966503,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LGALS4,Galectin-4,Inverse variance weighted,15,0.96 [0.91-1.02],0.183757711773975,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CREG1,Protein CREG1,Inverse variance weighted,20,0.95 [0.89-1.02],0.186883784780764,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.2 [0.91-1.57],0.19070320761654,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CCL27,C-C motif chemokine 27,Inverse variance weighted,9,1.62 [0.79-3.33],0.191505635670841,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,1.38 [0.85-2.23],0.194721257696734,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,0.88 [0.72-1.07],0.195327772266128,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,1.03 [0.98-1.09],0.197020298340295,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.95 [0.89-1.03],0.198657244700995,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.84 [0.64-1.1],0.201860950536963,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FOLR1,Folate receptor alpha,Inverse variance weighted,6,1.11 [0.94-1.32],0.205064284319012,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,1.06 [0.97-1.15],0.205454433287329,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PTPRB,Receptor-type tyrosine-protein phosphatase beta,Inverse variance weighted,16,1.04 [0.98-1.1],0.209612816184541,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1.38 [0.83-2.3],0.216309899879652,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ACE,Angiotensin-converting enzyme,Inverse variance weighted,27,1.03 [0.98-1.07],0.217008005329295,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,OCLN,Occludin,Inverse variance weighted,2,1.2 [0.9-1.61],0.217237790256185,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SDC1,Syndecan-1,Inverse variance weighted,12,1.11 [0.94-1.32],0.219057969013598,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FLT3LG,Fms-related tyrosine kinase 3 ligand,Inverse variance weighted,50,1.05 [0.97-1.13],0.221954939835502,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,7,0.87 [0.7-1.09],0.222945819823785,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,1.14 [0.92-1.42],0.227084121084311,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,INHBC,Inhibin beta C chain,Inverse variance weighted,12,1.09 [0.95-1.24],0.230162505435353,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,1.09 [0.95-1.26],0.231043002046529,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,1.12 [0.93-1.34],0.232281458497988,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,Inverse variance weighted,48,0.97 [0.92-1.02],0.233859842965254,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LAYN,Layilin,Inverse variance weighted,3,1.24 [0.87-1.77],0.233994164576064,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,2,0.76 [0.48-1.2],0.23723046167335,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,0.78 [0.52-1.18],0.240968062655012,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,1.18 [0.89-1.56],0.241689178507499,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IMMT,MICOS complex subunit MIC60,Wald ratio,1,0.81 [0.56-1.16],0.246274067564933,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Inverse variance weighted,6,0.89 [0.73-1.08],0.247034563172272,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CA14,Carbonic anhydrase 14,Inverse variance weighted,11,0.91 [0.79-1.06],0.247327948032302,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LGALS9,Galectin-9,Inverse variance weighted,36,0.98 [0.93-1.02],0.247403527153613,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,7,0.94 [0.84-1.05],0.247945237698761,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,RSPO3,R-spondin-3,Inverse variance weighted,5,0.77 [0.5-1.2],0.256095294189162,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FURIN,Furin,Inverse variance weighted,3,0.86 [0.67-1.11],0.256682192703495,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SERPIND1,Heparin cofactor 2,Inverse variance weighted,32,0.95 [0.86-1.04],0.258379603970592,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,1.15 [0.9-1.47],0.263147879701683,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,1.18 [0.88-1.59],0.26325486800396,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,GAST,Gastrin,Inverse variance weighted,9,0.93 [0.82-1.06],0.264750216062157,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,1.04 [0.97-1.13],0.265894381908808,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,GUCA2A,Guanylin,Inverse variance weighted,7,1.08 [0.94-1.25],0.270071294116161,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MFGE8,Lactadherin,Inverse variance weighted,15,1.13 [0.91-1.39],0.272145603140047,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",Inverse variance weighted,18,1.05 [0.97-1.13],0.272388068029443,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,1.27 [0.83-1.97],0.27359349121786,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,1.34 [0.79-2.27],0.274831153258243,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,9,1.23 [0.85-1.8],0.275245262943715,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.02 [0.98-1.06],0.279121425678706,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CCL18,C-C motif chemokine 18,Inverse variance weighted,19,0.98 [0.94-1.02],0.280517349786665,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,16,0.94 [0.85-1.05],0.283124509211512,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,34,1.02 [0.99-1.05],0.28314556340882,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,0.93 [0.82-1.06],0.2834063983172,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,1.08 [0.94-1.23],0.284050292011808,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,HGF,Hepatocyte growth factor,Inverse variance weighted,5,1.11 [0.91-1.36],0.285737454267996,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,1.02 [0.98-1.06],0.290614159336106,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,28,0.95 [0.86-1.05],0.292821529731491,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD302,CD302 antigen,Inverse variance weighted,11,0.92 [0.79-1.07],0.294076476769689,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,12,1.28 [0.81-2.02],0.294311510851741,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,1.08 [0.94-1.24],0.299836973450043,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LETM1,Mitochondrial proton/calcium exchanger protein,Inverse variance weighted,2,1.19 [0.86-1.64],0.301897957928257,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,1.09 [0.93-1.28],0.302454446080251,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD83,CD83 antigen,Inverse variance weighted,14,0.92 [0.79-1.08],0.30287216341361,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CHGA,Chromogranin-A,Inverse variance weighted,5,0.91 [0.77-1.08],0.305576382835716,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,10,1.08 [0.93-1.25],0.306492005061258,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,0.85 [0.62-1.17],0.310242057824404,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,1.11 [0.91-1.36],0.310775871539269,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD34,Hematopoietic progenitor cell antigen CD34,Inverse variance weighted,2,1.29 [0.79-2.13],0.311466265852754,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CFH,Complement factor H,Inverse variance weighted,7,1.07 [0.94-1.22],0.312186124066125,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,0.95 [0.86-1.05],0.31457380173228,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,RNASE4,Ribonuclease 4,Inverse variance weighted,2,0.85 [0.6-1.18],0.324531901158749,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,0.89 [0.72-1.12],0.325145634945147,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,UMOD,Uromodulin,Inverse variance weighted,34,0.96 [0.89-1.04],0.327675944363455,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,11,1.14 [0.87-1.49],0.330931304302446,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MET,Hepatocyte growth factor receptor,Inverse variance weighted,21,1.06 [0.94-1.21],0.331720281456125,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,1.18 [0.84-1.66],0.335415597573225,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LEP,Leptin,Inverse variance weighted,4,1.26 [0.79-1.99],0.336122308899896,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PGF,Placenta growth factor,Inverse variance weighted,5,0.92 [0.78-1.09],0.340222651919729,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SNCG,Gamma-synuclein,Inverse variance weighted,47,0.98 [0.95-1.02],0.340473535476758,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FABP6,Gastrotropin,Inverse variance weighted,4,0.89 [0.71-1.13],0.343043109648011,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,8,1.12 [0.88-1.42],0.350664442228013,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,22,1.03 [0.97-1.1],0.352683206749066,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SFTPD,Pulmonary surfactant-associated protein D,Inverse variance weighted,54,1.01 [0.98-1.04],0.353884296149453,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PDGFC,Platelet-derived growth factor C,Inverse variance weighted,10,0.94 [0.82-1.07],0.355614808234437,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,0.88 [0.67-1.16],0.358371490106375,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.87 [0.66-1.16],0.360224198109442,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LDLR,Low-density lipoprotein receptor,Inverse variance weighted,17,1.1 [0.9-1.35],0.362200426764394,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,1.08 [0.92-1.26],0.364195918305582,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,1.03 [0.96-1.1],0.364418498869228,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ITGA11,Integrin alpha-11,Inverse variance weighted,7,0.87 [0.65-1.17],0.364639196458381,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MENT,Protein MENT,Inverse variance weighted,28,1.04 [0.96-1.12],0.366216131676607,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,0.88 [0.66-1.17],0.371584979637163,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PTN,Pleiotrophin,Inverse variance weighted,3,0.84 [0.58-1.23],0.374934154557277,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IL12A_IL12B,Interleukin-12,Inverse variance weighted,56,0.98 [0.95-1.02],0.375972076240812,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD46,Membrane cofactor protein,Inverse variance weighted,2,0.86 [0.62-1.19],0.376344038584482,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SPON1,Spondin-1,Inverse variance weighted,4,1.1 [0.89-1.37],0.378563391303103,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CCL11,Eotaxin,Inverse variance weighted,11,1.03 [0.96-1.11],0.379061505817536,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,1.12 [0.87-1.46],0.380200166360443,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IL7R,Interleukin-7 receptor subunit alpha,Inverse variance weighted,25,0.96 [0.88-1.05],0.380549082911428,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1.21 [0.78-1.88],0.384473618574254,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,0.95 [0.85-1.07],0.387176493440359,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,1.06 [0.93-1.21],0.392970759159278,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,22,0.97 [0.91-1.04],0.393224784832342,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,BPIFB2,BPI fold-containing family B member 2,Inverse variance weighted,37,0.97 [0.91-1.04],0.393248139169272,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,1.17 [0.82-1.68],0.395014687707599,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ELN,Elastin,Inverse variance weighted,10,0.87 [0.62-1.21],0.396353812285699,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,DLL1,Delta-like protein 1,Inverse variance weighted,6,1.16 [0.82-1.65],0.400641368330318,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.03 [0.96-1.1],0.41978268773654,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,RNASE6,Ribonuclease K6,Inverse variance weighted,4,0.87 [0.62-1.23],0.422290276234488,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SCG3,Secretogranin-3,Inverse variance weighted,16,1.04 [0.94-1.16],0.427719443539584,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SERPINF1,Pigment epithelium-derived factor,Wald ratio,1,1.24 [0.73-2.09],0.428200659498833,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CHGB,Secretogranin-1,Inverse variance weighted,7,1.06 [0.91-1.23],0.429003705853911,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,INHBB,Inhibin beta B chain,Inverse variance weighted,11,1.06 [0.91-1.23],0.431496508565699,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,0.9 [0.68-1.18],0.431984104747796,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,1.06 [0.91-1.25],0.435659277429161,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,APOA2,Apolipoprotein A-II,Inverse variance weighted,15,0.93 [0.76-1.12],0.435944913305137,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,8,1.07 [0.9-1.27],0.438840623838093,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CALB1,Calbindin,Inverse variance weighted,9,1.05 [0.93-1.19],0.442382120322948,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,0.95 [0.82-1.09],0.447173491520425,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,1.06 [0.91-1.22],0.448655038377623,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,11,0.95 [0.82-1.09],0.459759061359663,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,0.77 [0.39-1.54],0.462916931267368,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CST3,Cystatin-C,Inverse variance weighted,3,0.81 [0.47-1.41],0.46397593669001,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SHISA5,Protein shisa-5,Inverse variance weighted,12,0.94 [0.81-1.1],0.46407609193868,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,DNM3,Dynamin-3,Inverse variance weighted,11,1.04 [0.93-1.16],0.464943554800781,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,REN,Renin,Inverse variance weighted,8,1.18 [0.76-1.82],0.468965042414102,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,1.05 [0.92-1.19],0.469295664118832,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,1.03 [0.95-1.12],0.472369675685404,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,0.95 [0.82-1.1],0.480598121167345,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MVK,Mevalonate kinase,Wald ratio,1,0.69 [0.24-1.96],0.480925215390462,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SOST,Sclerostin,Inverse variance weighted,31,1.03 [0.94-1.13],0.481126110554873,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,0.9 [0.66-1.22],0.48264017635223,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,XG,Glycoprotein Xg,Inverse variance weighted,2,0.89 [0.62-1.26],0.501473444634332,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,RAB6A,Ras-related protein Rab-6A,Inverse variance weighted,27,0.97 [0.89-1.06],0.502186472873954,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,13,1.06 [0.89-1.27],0.503524469534513,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CGA,Glycoprotein hormones alpha chain,Inverse variance weighted,2,0.71 [0.26-1.94],0.50573136980218,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.94 [0.77-1.14],0.510073289272195,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,6,1.14 [0.77-1.7],0.510508777314198,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CLEC4M,C-type lectin domain family 4 member M,Inverse variance weighted,35,1.01 [0.97-1.06],0.510538287416777,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,DPT,Dermatopontin,Inverse variance weighted,4,1.1 [0.83-1.45],0.514522025772209,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,HJV,Hemojuvelin,Inverse variance weighted,2,1.13 [0.79-1.61],0.518643087937506,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,0.78 [0.36-1.67],0.519067777793863,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,0.95 [0.81-1.12],0.520456373770359,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,0.9 [0.64-1.25],0.521589059724352,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,0.91 [0.68-1.22],0.521792012351914,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1.05 [0.91-1.22],0.521885834580218,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,0.98 [0.92-1.04],0.526160098027714,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,0.93 [0.75-1.16],0.527350314117808,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,1.07 [0.87-1.32],0.528483771455769,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,EPO,Erythropoietin,Inverse variance weighted,11,0.96 [0.84-1.09],0.533511530359713,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TFF2,Trefoil factor 2,Inverse variance weighted,16,0.96 [0.84-1.09],0.535000983987913,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NECTIN4,Nectin-4,Inverse variance weighted,4,1.13 [0.76-1.68],0.536179364079757,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,0.97 [0.88-1.07],0.537321590588685,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,1.09 [0.82-1.45],0.539275529943245,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,0.96 [0.85-1.09],0.540155576453639,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,0.98 [0.92-1.05],0.541269231063213,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,10,1.07 [0.86-1.34],0.54153159063604,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,1.04 [0.92-1.16],0.543137764839906,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.03 [0.93-1.14],0.544892704741887,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.04 [0.91-1.2],0.548893614708663,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CTSZ,Cathepsin Z,Inverse variance weighted,16,0.98 [0.94-1.04],0.55011060309391,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,0.91 [0.67-1.24],0.550690007470938,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,0.96 [0.85-1.09],0.551401417305554,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,GDF2,Growth/differentiation factor 2,Inverse variance weighted,31,0.98 [0.9-1.06],0.552082716099464,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,29,1.02 [0.96-1.09],0.552197719534806,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SPP1,Osteopontin,Inverse variance weighted,13,0.94 [0.76-1.16],0.552816235581217,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TFPI,Tissue factor pathway inhibitor,Inverse variance weighted,20,1.03 [0.93-1.14],0.554350526613723,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,1.13 [0.75-1.71],0.554577321365399,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CTSS,Cathepsin S,Inverse variance weighted,7,1.11 [0.78-1.57],0.55719479903964,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,1.44 [0.43-4.86],0.558853896718752,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PLXNB2,Plexin-B2,Inverse variance weighted,12,1.05 [0.88-1.26],0.563215418425172,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,0.92 [0.7-1.21],0.563634490249732,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,HYAL1,Hyaluronidase-1,Inverse variance weighted,19,1.02 [0.95-1.11],0.564503934769742,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,KLK4,Kallikrein-4,Inverse variance weighted,5,0.86 [0.5-1.46],0.567125299673201,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LGMN,Legumain,Inverse variance weighted,22,1.05 [0.9-1.22],0.569728540289183,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,1.05 [0.89-1.24],0.573101472352471,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.91 [0.67-1.25],0.578060491782304,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,0.91 [0.66-1.26],0.578601446062161,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,4,1.07 [0.85-1.35],0.579673134693594,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SERPINA5,Plasma serine protease inhibitor,Inverse variance weighted,7,0.97 [0.88-1.08],0.581419881823309,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD27,CD27 antigen,Inverse variance weighted,9,1.07 [0.84-1.35],0.583543878608839,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD160,CD160 antigen,Inverse variance weighted,24,0.97 [0.88-1.07],0.583618033798819,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TCN2,Transcobalamin-2,Inverse variance weighted,24,0.99 [0.94-1.04],0.585760749487809,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MDK,Midkine,Inverse variance weighted,14,1.03 [0.92-1.17],0.587725523832333,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,0.92 [0.68-1.25],0.587809229385808,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,1.1 [0.78-1.54],0.588289496585311,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FAM3B,Protein FAM3B,Inverse variance weighted,26,0.99 [0.95-1.03],0.589065611487462,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,14,1.03 [0.93-1.14],0.590432280221769,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SFTPA2,Pulmonary surfactant-associated protein A2,Inverse variance weighted,27,1.01 [0.98-1.04],0.591337643985805,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,1.01 [0.96-1.07],0.594948854518392,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,Inverse variance weighted,4,1.47 [0.36-6.02],0.596013990818475,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,APOE,Apolipoprotein E,Inverse variance weighted,6,1.06 [0.86-1.29],0.596989064971038,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,0.95 [0.8-1.14],0.597692723146224,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,4,1.15 [0.68-1.94],0.599589477710214,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,1.05 [0.87-1.27],0.600880625085556,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,3,0.95 [0.77-1.16],0.607493116184811,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,0.9 [0.6-1.35],0.60875545116741,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.93 [0.72-1.22],0.610763419200063,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,28,1.03 [0.92-1.15],0.621323365697057,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SEMA3G,Semaphorin-3G,Inverse variance weighted,66,0.99 [0.95-1.03],0.622617201368238,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LMNB2,Lamin-B2,Inverse variance weighted,8,1.05 [0.87-1.25],0.623384359399653,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,1.05 [0.86-1.29],0.62998524903474,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LY96,Lymphocyte antigen 96,Inverse variance weighted,16,1.03 [0.9-1.19],0.630642055862685,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CCL25,C-C motif chemokine 25,Inverse variance weighted,22,0.98 [0.9-1.07],0.631846771498313,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PGA4,Pepsin A-4,Inverse variance weighted,7,0.96 [0.82-1.13],0.633932447115072,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,0.97 [0.87-1.09],0.635282214234164,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CCL22,C-C motif chemokine 22,Inverse variance weighted,8,1.09 [0.77-1.53],0.637996758358216,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LPA,Apolipoprotein(a),Inverse variance weighted,2,1.1 [0.73-1.66],0.639605016448828,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,0.94 [0.73-1.22],0.642834119905368,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,0.94 [0.71-1.24],0.644011822741926,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD209,CD209 antigen,Inverse variance weighted,34,1.01 [0.97-1.06],0.647331223060569,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CCL20,C-C motif chemokine 20,Inverse variance weighted,6,1.04 [0.88-1.23],0.650536696709924,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,F7,Coagulation factor VII,Inverse variance weighted,10,0.96 [0.81-1.14],0.652407688330921,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,1.01 [0.95-1.08],0.653577196311718,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PALM2,Paralemmin-2,Inverse variance weighted,9,1.02 [0.94-1.11],0.654369705028754,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,19,0.98 [0.91-1.06],0.664196627081681,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,1.11 [0.69-1.77],0.668639135617198,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,0.98 [0.89-1.07],0.669355260920389,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,0.95 [0.74-1.21],0.670534390565626,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,1.05 [0.85-1.28],0.671129550355549,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NUCB2,Nucleobindin-2,Inverse variance weighted,2,1.18 [0.54-2.6],0.671479919528183,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,0.98 [0.87-1.1],0.679849612454931,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LGALS3,Galectin-3,Inverse variance weighted,15,1.03 [0.89-1.2],0.680386226787888,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,GAL,Galanin peptides,Inverse variance weighted,49,1.02 [0.93-1.11],0.681229276428895,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,1.02 [0.94-1.11],0.682815807758422,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,0.95 [0.75-1.21],0.695748654216543,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Wald ratio,1,1.1 [0.69-1.73],0.695871464663537,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FAM3C,Protein FAM3C,Inverse variance weighted,3,1.08 [0.73-1.6],0.69707014327409,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,0.97 [0.81-1.16],0.704089352020844,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.96 [0.78-1.18],0.704455049964607,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,0.96 [0.77-1.19],0.706389278513666,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,GHR,Growth hormone receptor,Inverse variance weighted,26,0.98 [0.89-1.08],0.706420163142238,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,1.07 [0.76-1.5],0.709176453069739,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IL13RA1,Interleukin-13 receptor subunit alpha-1,Inverse variance weighted,3,1.02 [0.9-1.17],0.709827462147806,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,1.08 [0.7-1.68],0.714090119621537,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,DKK4,Dickkopf-related protein 4,Inverse variance weighted,15,0.97 [0.83-1.14],0.716180942208793,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CTSL,Cathepsin L1,Inverse variance weighted,29,0.98 [0.9-1.08],0.716678050941251,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,0.94 [0.68-1.3],0.721915563922603,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,KLB,Beta-klotho,Inverse variance weighted,23,1.01 [0.94-1.1],0.723715380128601,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.1 [0.65-1.88],0.724161626921167,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,17,0.98 [0.88-1.1],0.72810705978823,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,THPO,Thrombopoietin,Inverse variance weighted,12,0.98 [0.87-1.1],0.729719593199311,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,1.02 [0.93-1.11],0.732605750180201,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,1.02 [0.91-1.14],0.732809897352628,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,1.01 [0.97-1.04],0.735998103324486,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,RSPO1,R-spondin-1,Inverse variance weighted,8,1.03 [0.87-1.22],0.737209434599714,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PSAP,Prosaposin,Inverse variance weighted,13,1.01 [0.94-1.09],0.739957254275881,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FGFBP2,Fibroblast growth factor-binding protein 2,Inverse variance weighted,38,1.01 [0.96-1.05],0.742565815722047,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CTSB,Cathepsin B,Inverse variance weighted,28,0.99 [0.91-1.07],0.744244057906474,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PALM,Paralemmin-1,Inverse variance weighted,4,1.06 [0.73-1.55],0.746342053932919,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,6,0.97 [0.81-1.16],0.746983804540883,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CCN3,CCN family member 3,Inverse variance weighted,17,1.02 [0.89-1.17],0.75083927690862,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,BSG,Basigin,Inverse variance weighted,6,1.05 [0.76-1.47],0.751642586173932,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,0.94 [0.6-1.45],0.766014679457897,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,1.08 [0.65-1.8],0.769829040034047,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,S100G,Protein S100-G,Inverse variance weighted,4,0.97 [0.79-1.19],0.772127612341235,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,16,1.01 [0.91-1.13],0.783468700350072,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,1.01 [0.91-1.12],0.793263949753781,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IL19,Interleukin-19,Inverse variance weighted,10,0.99 [0.93-1.05],0.795811977235436,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,23,0.99 [0.92-1.06],0.796219450403456,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,6,1.04 [0.75-1.45],0.797466778307917,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,1.07 [0.64-1.79],0.800266990427198,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,1.01 [0.92-1.11],0.801512874380703,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,0.99 [0.92-1.07],0.801736075306882,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,KLK11,Kallikrein-11,Inverse variance weighted,13,0.98 [0.87-1.11],0.802771544842712,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NECTIN2,Nectin-2,Inverse variance weighted,3,0.96 [0.68-1.35],0.803430579707105,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,6,1.03 [0.83-1.27],0.804152233496994,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,XCL1,Lymphotactin,Inverse variance weighted,15,0.97 [0.79-1.2],0.805437157469721,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,0.98 [0.82-1.16],0.806616162425311,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,1.02 [0.88-1.17],0.80781988781708,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,F13B,Coagulation factor XIII B chain,Inverse variance weighted,10,1.01 [0.93-1.1],0.808851137663327,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CALCA,Calcitonin,Inverse variance weighted,13,0.98 [0.81-1.18],0.809327966221791,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,Inverse variance weighted,14,0.98 [0.79-1.2],0.818872199402023,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NFASC,Neurofascin,Inverse variance weighted,6,1.04 [0.74-1.45],0.822993886264307,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PRSS8,Prostasin,Inverse variance weighted,14,0.98 [0.86-1.13],0.826722935463305,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,AMBP,Protein AMBP,Inverse variance weighted,5,0.97 [0.76-1.24],0.826783278116828,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1 [0.97-1.02],0.8274801555189,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,KDR,Vascular endothelial growth factor receptor 2,Inverse variance weighted,25,1.01 [0.91-1.13],0.82797920803616,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FOLR2,Folate receptor beta,Inverse variance weighted,14,0.99 [0.89-1.09],0.835183197840414,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,AOC3,Membrane primary amine oxidase,Inverse variance weighted,33,1 [0.95-1.04],0.837261921908288,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SIT1,Signaling threshold-regulating transmembrane adapter 1,Inverse variance weighted,7,1.03 [0.76-1.39],0.838752696435408,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,15,0.99 [0.89-1.1],0.842863092248915,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SEPTIN8,Septin-8,Inverse variance weighted,4,1.02 [0.84-1.23],0.84322091777041,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,1.01 [0.88-1.16],0.845335671185411,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,1.01 [0.93-1.1],0.846819377907491,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,3,0.97 [0.73-1.29],0.851891607883808,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,0.98 [0.82-1.18],0.855426016837428,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,1.02 [0.86-1.2],0.856754194338854,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,29,1.01 [0.91-1.12],0.858268707823119,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,1.03 [0.75-1.42],0.858296925167667,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PENK,Proenkephalin-A,Inverse variance weighted,15,0.99 [0.88-1.11],0.85922774421167,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CDH2,Cadherin-2,Inverse variance weighted,21,0.99 [0.83-1.16],0.862694369808546,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,STC1,Stanniocalcin-1,Inverse variance weighted,9,0.98 [0.79-1.22],0.866770539954775,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PLAT,Tissue-type plasminogen activator,Inverse variance weighted,5,1.01 [0.85-1.21],0.872930779702064,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,0.99 [0.89-1.1],0.875036792735656,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,0.99 [0.82-1.18],0.87531531222896,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,0.98 [0.79-1.22],0.875596918447022,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,1.07 [0.47-2.43],0.877032717056577,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,POF1B,Protein POF1B,Inverse variance weighted,4,0.98 [0.8-1.21],0.87818931675972,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,1.03 [0.72-1.47],0.879350987267639,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PLTP,Phospholipid transfer protein,Inverse variance weighted,30,1.01 [0.94-1.07],0.880664640911389,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MMP7,Matrilysin,Wald ratio,1,0.99 [0.81-1.19],0.88320362246297,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,Inverse variance weighted,14,1.02 [0.82-1.26],0.883301818774649,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,0.97 [0.61-1.53],0.88396458773915,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,RNASET2,Ribonuclease T2,Inverse variance weighted,10,1.02 [0.8-1.3],0.885139289481733,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,1.02 [0.78-1.34],0.886332198237109,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,18,1.01 [0.89-1.14],0.889573562247103,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,EFNA4,Ephrin-A4,Inverse variance weighted,2,0.96 [0.54-1.72],0.891846046536519,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,1.01 [0.85-1.21],0.892296225894553,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD58,Lymphocyte function-associated antigen 3,Inverse variance weighted,6,0.99 [0.85-1.15],0.892490938417976,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,1.02 [0.71-1.48],0.895751003728967,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.01 [0.88-1.15],0.896958720686182,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,1 [0.96-1.05],0.902969462337748,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,DPP4,Dipeptidyl peptidase 4,Inverse variance weighted,8,0.99 [0.82-1.19],0.905287868243162,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,1 [0.95-1.05],0.905970299411208,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,DRAXIN,Draxin,Inverse variance weighted,25,1.01 [0.92-1.1],0.906207296809508,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ITGAV,Integrin alpha-V,Inverse variance weighted,10,0.99 [0.83-1.18],0.907265296123044,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.97 [0.62-1.52],0.910233687223641,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CCN5,CCN family member 5,Inverse variance weighted,12,1 [0.93-1.07],0.915298156965363,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,12,0.99 [0.79-1.24],0.915681931858994,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,25,1.01 [0.89-1.13],0.921187663471671,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,0.99 [0.89-1.11],0.922354493172965,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.09 [0.2-5.91],0.924022323927224,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NPPC,C-type natriuretic peptide,Inverse variance weighted,3,0.98 [0.64-1.51],0.932103644694105,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,15,1 [0.9-1.1],0.934376589874834,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,1.01 [0.73-1.41],0.936504774871009,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.99 [0.73-1.34],0.938688717985411,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,0.99 [0.72-1.35],0.942813591101915,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,12,1.01 [0.84-1.21],0.949783099087113,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,XPNPEP2,Xaa-Pro aminopeptidase 2,Inverse variance weighted,20,1 [0.91-1.1],0.952368638322871,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,12,1 [0.87-1.15],0.954307830333043,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,TNFSF10,Tumor necrosis factor ligand superfamily member 10,Inverse variance weighted,20,1 [0.88-1.13],0.954705023270388,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,COLEC12,Collectin-12,Inverse variance weighted,3,1.02 [0.6-1.72],0.955784401992171,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,1 [0.9-1.11],0.956049960174617,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,NRP2,Neuropilin-2,Inverse variance weighted,14,1 [0.84-1.2],0.956185175266256,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.01 [0.66-1.56],0.957396419314057,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,11,1.01 [0.81-1.26],0.959274682184637,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CFI,Complement factor I,Wald ratio,1,0.98 [0.52-1.84],0.959451145001682,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,0.99 [0.73-1.35],0.959709444730235,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,1 [0.88-1.14],0.963656844235329,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,1 [0.85-1.18],0.964255217779782,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,AGRN,Agrin,Inverse variance weighted,14,1 [0.81-1.25],0.974545395296508,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,1 [0.88-1.14],0.976845498467948,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,1 [0.92-1.09],0.978145778475719,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,1 [0.7-1.42],0.985228268098689,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,SCG2,Secretogranin-2,Inverse variance weighted,2,1 [0.77-1.3],0.985238629999594,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ROBO2,Roundabout homolog 2,Inverse variance weighted,6,1 [0.87-1.15],0.987696711375946,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,CD59,CD59 glycoprotein,Inverse variance weighted,4,1 [0.81-1.23],0.993051794372995,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,FBLN2,Fibulin-2,Inverse variance weighted,6,1 [0.76-1.31],0.995317590918735,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,1 [0.74-1.34],0.99795005583814,trans
Chapter IX Diseases of the circulatory system,I9_MI_STRICT,ACAN,Aggrecan core protein,Inverse variance weighted,30,1 [0.9-1.11],0.998189552792808,trans
